[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[S. 2013 Introduced in Senate (IS)]







110th CONGRESS
  1st Session
                                S. 2013

 To initially apply the required use of tamper-resistant prescription 
 pads under the Medicaid Program to schedule II narcotic drugs and to 
 delay the application of the requirement to other prescription drugs 
                             for 18 months.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                             August 3, 2007

  Mr. Brown (for himself and Mr. Voinovich) introduced the following 
  bill; which was read twice and referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL


 
 To initially apply the required use of tamper-resistant prescription 
 pads under the Medicaid Program to schedule II narcotic drugs and to 
 delay the application of the requirement to other prescription drugs 
                             for 18 months.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Patient and Pharmacy Protection Act 
of 2007''.

SEC. 2. PHASED-IN REQUIREMENT TO USE TAMPER-RESISTANT PRESCRIPTION PADS 
              UNDER MEDICAID; INITIAL APPLICATION TO SCHEDULE II 
              NARCOTIC DRUGS.

    Effective as if included in the enactment of section 7002(b) of the 
U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq 
Accountability Appropriations Act, 2007 (Public Law 110-28), paragraph 
(2) of such section is amended to read as follows:
            ``(2) Phased-in application.--The amendments made by 
        paragraph (1) shall apply--
                    ``(A) with respect to covered outpatient drugs (as 
                defined in section 1927(k)(2)) which are narcotic drugs 
                included in schedule II of section 202 of the 
                Controlled Substances Act (21 U.S.C. 812), to 
                prescriptions for such drugs executed after September 
                30, 2007; and
                    ``(B) with respect to any other covered outpatient 
                drugs (as so defined), to prescriptions executed after 
                March 31, 2009.''.
                                 <all>